Evolent Health (EVH) said Tuesday that Rick Jelinek has been named the company's new board chairman, effective at the company's next annual meeting.
The specialty health care company said Jelinek will succeed Cheryl Scott as chair.
Jelinek, who is managing partner at Czech One Capital Partners and previously was an executive vice president at CVS Health (CVS), joined the Evolent board in 2023.
Evolent also said health care investor Brendan Springstubb will join the board as an independent director when Scott steps down after three years on the panel.
The company also said its board plans to select another independent member, with directors on its nominating and governance committee now evaluating potential director nominees.
Price: 10.26, Change: +0.04, Percent Change: +0.44
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。